Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

May 30, 2026

Atlanta Based Health Center celebrates 50 Years of Service

May 30, 2026

Taklimakan Rally 2026: GWM TANK Dominates the Unforgiving Desert

May 30, 2026

12B SPORTS Named Main Sponsor of VR46 Racing Team for the 2026 MotoGP Season

May 30, 2026

Quebec municipalities group calls government to address public transit underfunding

May 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Enlitic Announces Ensight 2.2, a Breakthrough in Imaging Data Standardization
Press Release

Enlitic Announces Ensight 2.2, a Breakthrough in Imaging Data Standardization

By News RoomApril 14, 20262 Mins Read
Enlitic Announces Ensight 2.2, a Breakthrough in Imaging Data Standardization
Share
Facebook Twitter LinkedIn Pinterest Email

LOVELAND, Colo., April 14, 2026 (GLOBE NEWSWIRE) — Enlitic has announced Ensight 2.2, a breakthrough release for its imaging data platform. Building on the innovations introduced in Ensight 2.1, version 2.2 gives health systems and partners a clearer, more detailed understanding of imaging data and accelerates the path from implementation to impact.

Ensight 2.1 laid the groundwork for a more flexible approach to aligning imaging data with customer terminology and workflow requirements. Ensight 2.2 builds on that foundation with stronger tools for configuring, testing, and refining how information flows across downstream systems. The result is a faster route to deployment, less friction during validation, and greater confidence that each system receives information the right way.

“Ensight 2.2 gives customers an unprecedented way to see and use their imaging data,” said Michael Sistenich, CEO of Enlitic. “Instead of treating imaging data as a black box, this release helps teams understand its condition, identify issues, and uncover opportunities to improve how data supports their operations.”

The release also includes platform and deployment enhancements that improve throughput, expand support for more complex imaging data, and strengthen teams’ ability to search studies, build representative data sets, compare configurations, and validate results against human-labeled ground truth. Together, these updates help remove bottlenecks, handle higher imaging volumes more efficiently, and improve performance reliability, bringing clarity and predictability to teams’ operations.

For organizations seeking to reduce manual cleanup, workflow exceptions, and the hidden operational costs of inconsistent imaging data, Ensight 2.2 supports a more controlled and transparent approach across systems and sites. By helping teams spot issues sooner and refine data delivery with greater precision, the release can reduce disruptions and streamline day-to-day workflows.

To learn more about Ensight, visit enlitic.com.

About Enlitic
Enlitic is a software company that uses artificial intelligence to develop software products that manage medical imaging data in radiology such as MRI, CT scans, X-ray and ultrasound images and licenses such products to healthcare providers. Enlitic’s products, including its current product offering and product suite under development, seek to standardize, protect, integrate, and analyze data to create the foundation of a real-world evidence platform that can improve clinical workflows, increase efficiencies, and expand capacity. Read more at enlitic.com.

[email protected]
1-877-365-4842

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/372da620-5254-4763-8d1e-53195694c648

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Atlanta Based Health Center celebrates 50 Years of Service

Taklimakan Rally 2026: GWM TANK Dominates the Unforgiving Desert

12B SPORTS Named Main Sponsor of VR46 Racing Team for the 2026 MotoGP Season

Enabled Talent Hosts Cross-Party MPP Breakfast Reception at Queen’s Park During National AccessAbility Week

Monument’s Drill Assay Results Highlight Selinsing Gold Mine Expansion Potential

Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00

Renown Jazz Artists Hit the Stage to Help Georgians Receive Healthcare

A New Chapter Is Emerging in Pakistan-China Relations

Editors Picks

Atlanta Based Health Center celebrates 50 Years of Service

May 30, 2026

Taklimakan Rally 2026: GWM TANK Dominates the Unforgiving Desert

May 30, 2026

12B SPORTS Named Main Sponsor of VR46 Racing Team for the 2026 MotoGP Season

May 30, 2026

Quebec municipalities group calls government to address public transit underfunding

May 30, 2026

Latest News

Global News’ Dawna Friesen wins Canadian Screen Award for Best National News Anchor

May 30, 2026

New Brunswick graduates face big decisions as province tries to retain young talent

May 30, 2026

Penticton residents displaced due to safety risk from compromised crane following fire

May 29, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version